The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 16, 2018
Filed:
Jul. 25, 2014
Applicant:
N.v. Nutricia, Zoetermeer, NL;
Inventors:
Klaske Van Norren, Renkum, NL;
Joyce Faber, Goor, NL;
Adrianus Lambertus Bertholdus Van Helvoort, Wageningen, NL;
Robert Johan Joseph Hageman, Wageningen, NL;
Assignee:
N.V. Nutricia, , NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61P 7/00 (2006.01); A61K 31/202 (2006.01); A61K 31/198 (2006.01); A61K 31/715 (2006.01); A61K 45/06 (2006.01); A61K 31/702 (2006.01); A61K 38/02 (2006.01); A23L 33/12 (2016.01); A23L 33/17 (2016.01); A23L 33/175 (2016.01);
U.S. Cl.
CPC ...
A61K 31/202 (2013.01); A23L 33/12 (2016.08); A23L 33/17 (2016.08); A23L 33/175 (2016.08); A61K 31/198 (2013.01); A61K 31/702 (2013.01); A61K 31/715 (2013.01); A61K 38/02 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract
The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.